Experienced in Gallbladder Disease

Dirk H. Walter

Frankfurt Am Main, HE, DE 
Experienced in Gallbladder Disease
Frankfurt Am Main, HE, DE 
OverviewLocationsClinical Research

Overview

Dirk Walter practices in Frankfurt Am Main, Germany. Mr. Walter is rated as an Experienced expert by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Bile Duct Obstruction, Cerebral Hypoxia, Gastrostomy, and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 60 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Gallbladder Disease.

Gender
Male

Locations

Frankfurt Am Main, HE 60590, Germany
Other Locations
Giessen, HE, Germany
Langen, NI, Germany
Hamburg, HH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

(Restoration of Nerve Functions by Intra-arterial Transplantation of Bone Marrow Progenitor Cells in Patients With Diabetic Poly Neuropathy (PNP)
(Restoration of Nerve Functions by Intra-arterial Transplantation of Bone Marrow Progenitor Cells in Patients With Diabetic Poly Neuropathy (PNP)
Enrollment Status: Completed
Publish Date: October 26, 2021
Intervention Type: Procedure
Study Phase: Phase 1
The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction.
The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction.
Enrollment Status: Completed
Publish Date: April 13, 2021
Intervention Type: Procedure
Study Phase: Phase 3
View 1 Less Clinical Trial

60 Total Publications

Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients.
Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients.
Journal: Journal of cancer research and clinical oncology
Published: February 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Walter's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile